Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Advantage Risk Management Co., Ltd. (8769.T)
Tokyo, JP
Advantage Risk Management Co., Ltd. is a Japanese company specializing in comprehensive mental well-being and disability assistance. Their mental health division offers psychological care services, including preventative measures, intervention for employee mental health concerns, and programs designed to help staff successfully return to work. They also provide recruitment support through their Emotional Intelligence (EQ) service, utilizing EQ-based assessments and corporate training modules to develop emotional competencies. Regarding disability assistance, the company advises on implementing group long-term disability insurance schemes and provides post-implementation operational support, in addition to offering structured programs for employees returning from extended leave. Furthermore, Advantage Risk Management delivers risk financing solutions through a diverse range of insurance policies. The company was founded in 1999 and is headquartered in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.54% | +4.18% | +2.26% | -5.14% | -20.95% | -19.02% | -16.86% | -1.97% | -32.52% | +15.68% | +5.96% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+16.0% ★ Q1'26: +2.6% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-5.2% Q1'26: -55.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+17.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+10.1% Q1'26: +13.5% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+16.9% ★ Q1'26: +24.8% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-2.7% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.72× ★ Q1'26: 0.59× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
|---|---|---|---|---|---|---|---|---|
| Revenue |
4.48B
est: 4.61B (-2.8%)
|
4.90B
est: 5.19B (-5.6%)
|
5.26B
est: 5.29B (-0.5%)
|
5.45B
est: 5.43B (+0.4%)
|
5.79B
est: 6.20B (-6.6%)
|
6.41B
est: 6.70B (-4.4%)
|
7.00B
est: 7.50B (-6.7%)
|
8.55B
est: 8.40B (+1.8%)
|
| EBITDA |
1.13B
est: 805.58M (+40.3%)
|
1.23B
est: 906.93M (+35.4%)
|
1.23B
est: 924.41M (+32.8%)
|
993.87M
est: 948.87M (+4.7%)
|
750.83M
est: 1.08B (-30.7%)
|
1.08B
est: 1.17B (-7.5%)
|
1.40B
est: 1.35B (+3.7%)
|
1.86B
est: 1.55B (+19.9%)
|
| EBIT |
819.44M
est: 442.52M (+85.2%)
|
928.44M
est: 498.19M (+86.4%)
|
952.98M
est: 507.79M (+87.7%)
|
726.81M
est: 521.23M (+39.4%)
|
352.77M
est: 595.14M (-40.7%)
|
553.23M
est: 643.14M (-14.0%)
|
725.83M
est: 755.76M (-4.0%)
|
1.02B
est: 791.39M (+29.2%)
|
| Net Income |
564.44M
est: 529.32M (+6.6%)
|
614.85M
est: 650.36M (-5.5%)
|
639.30M
est: 590.65M (+8.2%)
|
496.22M
est: 400.22M (+24.0%)
|
201.81M
est: 484.14M (-58.3%)
|
377.61M
est: 426.04M (-11.4%)
|
505.58M
est: 503.50M (+0.4%)
|
744.36M
est: 584.10M (+27.4%)
|
| SGA |
2.66B
est: 2.86B (-6.8%)
|
2.91B
est: 3.22B (-9.7%)
|
3.09B
est: 3.28B (-5.7%)
|
3.47B
est: 3.37B (+3.2%)
|
3.87B
est: 3.84B (+0.6%)
|
4.01B
est: 4.15B (-3.5%)
|
4.19B
est: 4.65B (-9.8%)
|
4.86B
est: 5.07B (-4.0%)
|
| EPS |
33.02
est: 32.80 (+0.7%)
|
36.15
est: 40.30 (-10.3%)
|
37.74
est: 36.60 (+3.1%)
|
29.25
est: 24.80 (+17.9%)
|
12.07
est: 30.00 (-59.8%)
|
22.64
est: 26.40 (-14.2%)
|
30.30
est: 31.20 (-2.9%)
|
46.13
est: 37.20 (+24.0%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daisuke Kanesashi | Executive Officer | — | — |
| Junya Tsuru | Senior Executive Officer | — | — |
| Kaname Sakamoto | Senior Executive Officer | — | — |
| Kensuke Sumida | Senior Executive Officer, Head of Mental Management Business Division & Director | — | male |
| Satoko Okita | Executive Officer | — | — |
| Shinji Torigoe | President, Chief Executive Officer, Head of Internal Audit & Health Management Dept and Representative Director | — | male |
| Takayuki Amada | Senior Executive Officer, Head of Corporate Division & Director | — | male |
| Taku Kikuta | Executive Officer | — | — |
| Yasushi Fujiwara | Executive Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 8769.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
